Skip to search formSkip to main contentSkip to account menu

MK-231

Known as: MK 231, MK231 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1977
1977
Die medikamentöse Behandlung der rheumatoiden Arthritis ist nicht denkbar ohne den Einsatz eines symptomatisch wirkenden… 
1977
1977
MK-231 (Sulindac), 200-400 mg daily, was given to 25 patients with rheumatoid arthritis. The therapeutic response was good and… 
1977
1977
In a comparative study new antiinflammatory agents, like sodium-(3-[(2,6-dichlorephenyl)-amino5-phenyl)-acetate (diclofenac); d,l…